Sol J. Barer

Insider Reports History

Location
Boston, MA
Signature
/s/ Dov Bergwerk as attorney-in-fact for Sol J. Barer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sol J. Barer:

Company Role Class Num Shares Value Price $ Report Date Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Director Ordinary Shares 426,272 $7,255,277 $17.02 06 Jun 2025 Direct
NexImmune, Inc. Director Stock Option (right to buy) 44,983 05 Jul 2023 Direct
CONTRAFECT Corp Director Options (Right to Buy) 42,000 17 May 2022 Direct
Cerecor Inc. Director Stock Option (Right to Buy) 40,000 15 Jun 2021 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD Director Restricted Share Units 21,739 05 Jun 2025 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD Director Restricted Share Units 0 15 Jun 2024 Direct

Insider Reports Filed by Sol J. Barer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 05 Jun 2025 3 $0 4 Director 09 Jun 2025, 16:05
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 15 Jun 2024 2 $0 4 Director 17 Jun 2024, 07:14
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 07:31
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 04 Aug 2023 2 $0 4 Director 07 Aug 2023, 16:02
/report/000095017023032245-barer-sol-j-2023-07-05 NexImmune, Inc. 05 Jul 2023 1 $0 4 Director 07 Jul 2023, 16:16
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 07:31
/report/000120919123023681-barer-sol-j-2023-04-04 NexImmune, Inc. 04 Apr 2023 6 $0 4 Director 06 Apr 2023, 20:34
/report/000120919123021889-barer-sol-j-2023-03-30 NexImmune, Inc. 30 Mar 2023 1 +$164,120 4 Director 31 Mar 2023, 16:56
/report/000120919122057746-barer-sol-j-2022-11-16 NexImmune, Inc. 16 Nov 2022 2 +$96,218 4 Director 17 Nov 2022, 19:40
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 04 Aug 2022 1 $0 4 Director 08 Aug 2022, 07:10
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 07:32
/report/000120919122037010-barer-sol-j-2022-06-13 NexImmune, Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:57
/report/000120919122033727-barer-sol-j-2022-05-31 NexImmune, Inc. 31 May 2022 3 +$226,154 4 Director 02 Jun 2022, 19:41
/report/000120919122030193-barer-sol-j-2022-05-17 CONTRAFECT Corp 17 May 2022 1 +$140,700 4 Director 18 May 2022, 17:59
/report/000120919122020914-barer-sol-j-2022-03-23 NexImmune, Inc. 23 Mar 2022 1 +$26,653 4 Director 24 Mar 2022, 16:15
/report/000120919122020766-barer-sol-j-2022-03-22 NexImmune, Inc. 22 Mar 2022 1 +$72,300 4 Director 23 Mar 2022, 16:15
/report/000120919122020522-barer-sol-j-2022-03-21 NexImmune, Inc. 21 Mar 2022 1 +$64,080 4 Director 22 Mar 2022, 16:15
/report/000120919122020256-barer-sol-j-2022-03-18 NexImmune, Inc. 18 Mar 2022 1 +$63,210 4 Director 21 Mar 2022, 16:10
/report/000120919121070879-barer-sol-j-2021-12-21 NexImmune, Inc. 21 Dec 2021 2 +$258,500 4 Director 22 Dec 2021, 07:00
AVTX Cerecor Inc. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:33
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 14 Jun 2021 1 $0 4 Director 16 Jun 2021, 08:10
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 09 Jun 2021 2 $0 4 Director 10 Jun 2021, 07:39
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 05 Jun 2021 2 $0 4 Director 08 Jun 2021, 07:23
/report/000120919121034647-barer-sol-j-2021-05-18 CONTRAFECT Corp 18 May 2021 1 $0 4 Director 20 May 2021, 19:43
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .